Fibroblast Growth Factor Receptor (FGFR) Alterations in HPV Oropharyngeal Cancers

被引:0
|
作者
Bhateja, Priyanka [1 ]
Liu, Xuefeng [2 ]
Baliga, Sujith [3 ]
Gogineni, Emile [3 ]
Jhawar, Sachin [3 ]
Mitchell, Darrion [3 ]
Ma, Sungjun [3 ]
Zhu, Simeng [3 ]
Konieczkowski, David [3 ]
Blakaj, Dukagjin [3 ]
Old, Matthew [4 ]
Rocco, James [4 ]
Bonomi, Marcelo [1 ]
机构
[1] Ohio State Univ, James Canc Ctr, Dept Med Oncol, Columbus, OH 43210 USA
[2] Ohio State Univ, James Canc Ctr, Dept Pathol, Columbus, OH USA
[3] Ohio State Univ, James Canc Ctr, Dept Radiat Oncol, Columbus, OH USA
[4] Ohio State Univ, James Canc Ctr, Dept Otolaryngol, Columbus, OH USA
关键词
cellular effect; genomic instability; human papillomavirus; oncogenesis; proto-oncogenes; virus classification; HEAD;
D O I
10.1002/jmv.70086
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
HPV viral E6 and E7 onco-proteins play a well-known role in carcinogenesis. Host genomic alterations also play a key role in the development of HPV-related oropharyngeal cancer and have been under-recognized. We describe a case series of 6 metastatic/locoregionally recurrent HPVOPSCC patients with FGFR alterations. HPVOPSCC presents with distinct pattern of spread both temporally and sites of recurrence compared to non-HPV-related oropharyngeal cancer. Identification and reporting of genomic alterations in HPV are crucial to the understanding of disease biology and could aid in development of novel therapeutics for these patients. In addition, use of circulating tumor DNA may lead to early detection and supplement imaging in the follow up of these patients. Loco-regional treatments may also play a key role in the management of metastatic HPV OPSCC depending on the pattern of presentation. Our case series highlights all these novelties that could lead to better treatment outcomes.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Fibroblast Growth Factor Receptor (FGFR) amplifications in bladder cancer: A rare event
    Gaisa, N.
    Fischbach, A.
    Rogler, A.
    Erber, R.
    Stoehr, R.
    Poulsom, R.
    Schneevoigt, B. -S.
    Hauke, S.
    Hartmann, A.
    Veeck, J.
    Knuechel, R.
    VIRCHOWS ARCHIV, 2014, 465 : S170 - S170
  • [22] Targeting fibroblast growth factor receptor (FGFR) pathway in renal cell carcinoma
    Massari, Francesco
    Ciccarese, Chiara
    Santoni, Matteo
    Lopez-Beltran, Antonio
    Scarpelli, Marina
    Montironi, Rodolfo
    Cheng, Liang
    EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (12) : 1367 - 1369
  • [23] Fibroblast growth factor receptor (FGFR) inhibitors: A review of a novel therapeutic class
    Weaver, April
    Bossaer, John B.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (03) : 702 - 710
  • [24] Fibroblast growth factor receptor (FGFR)-3 as a suitable target in bladder cancer
    Gust, Kilian M.
    McConkey, David J.
    Hegarty, Paul K.
    Bondaruk, Jolanta E.
    Czerniak, Bogdan A.
    Dinney, Colin P.
    Black, Peter C.
    CANCER RESEARCH, 2011, 71
  • [25] Fibroblast growth factor receptor (FGFR) and inherited disorders of endochondral and intramembranous ossification
    Bonaventure, J
    Rousseau, F
    LegeaiMallet, L
    Benoist, C
    LeMerrer, M
    Munnich, A
    M S-MEDECINE SCIENCES, 1996, 12 : 44 - 49
  • [26] The natural history of fibroblast growth factor receptor (FGFR)-altered cholangiocarcinoma (CCA).
    Goyal, Lipika
    Lamarca, Angela
    Strickler, John H.
    Cecchini, Michael
    Ahn, Daniel H.
    Baiev, Islam
    Boileve, Alice
    Tazdait, Melodie
    Hannan, Lindsay Marie
    Jia, Jingquan
    Marble, Hetal Desai
    Barzi, Afsaneh
    Sahai, Vaibhav
    Lennerz, Jochen K.
    Kelley, Robin Kate
    Bekaii-Saab, Tanios S.
    Javle, Milind M.
    Uboha, Nataliya Volodymyrivna
    Harris, William P.
    Hollebecque, Antoine
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [27] Discovery of Pemigatinib: A Potent and Selective Fibroblast Growth Factor Receptor (FGFR) Inhibitor
    Wu, Liangxing
    Zhang, Colin
    He, Chunhong
    Qian, Dingquan
    Lu, Liang
    Sun, Yaping
    Xu, Meizhong
    Zhuo, Jincong
    Liu, Phillip C. C.
    Klabe, Ronald
    Wynn, Richard
    Covington, Maryanne
    Gallagher, Karen
    Leffet, Lynn
    Bowman, Kevin
    Diamond, Sharon
    Koblish, Holly
    Zhang, Yue
    Soloviev, Maxim
    Hollis, Gregory
    Burn, Timothy C.
    Scherle, Peggy
    Yeleswaram, Swamy
    Huber, Reid
    Yao, Wenqing
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (15) : 10666 - 10679
  • [28] Fibroblast Growth Factor Receptor (FGFR) Signaling in GIST and Soft Tissue Sarcomas
    Napolitano, Andrea
    Ostler, Alexandra E.
    Jones, Robin L.
    Huang, Paul H.
    CELLS, 2021, 10 (06)
  • [29] Fibroblast growth factor receptor (FGFR) 4 correlated with the malignancy of human astrocytomas
    Yamada, SM
    Yamada, S
    Hayashi, Y
    Takahashi, H
    Teramoto, A
    Matsumoto, K
    NEUROLOGICAL RESEARCH, 2002, 24 (03) : 244 - 248
  • [30] Fibroblast growth factor receptor (FGFR) mutations in achondroplasia and related skeletal dysplasias
    Rasar, MA
    Cho, J
    Lunstrum, GP
    Horton, WA
    GROWTH PLATE, 2002, 54 : 175 - 181